Evaxion Biotech A/S - ADR EVAX

NAS: EVAX | ISIN: US29970R1059 20/03/2026

3,910 USD (-2,25%)

(-2,25%) 20/03/2026

Grafiek Evaxion Biotech A/S - ADR

Grafiek Evaxion Biotech A/S - ADR

1 dag1d -2,25%
1 week1w 2,36%
1 maand1m 20,68%
3 maanden3m -23,78%
6 maanden6m 28,20%
1 jaar1j 106,88%
5 jaar5j -49,68%

Evaxion Biotech A/S - ADR in het nieuws

Toon enkel gratis nieuws

19 maart 2026 · Notice to convene Evaxion’s Annual General Meeting · Persbericht

17 maart 2026 · Evaxion to present new data at AACR Annual Meeting · Persbericht

5 maart 2026 · Evaxion announces business update and full year 2025 financial results · Persbericht

5 maart 2026 · Evaxion plans to file 2025 annual report later today · Persbericht

2 maart 2026 · Evaxion to announce business update and full year 2025 financial results on March 5, 2026 · Persbericht

13 januari 2026 · Evaxion expands AI-Immunology™ platform into autoimmune diseases · Persbericht

7 januari 2026 · Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week · Persbericht

19 december 2025 · Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 · Persbericht

6 december 2025 · Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting · Persbericht

20 november 2025 · Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe